Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$571,432
-$35,512 QoQ
Shares Held
2,250
-9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,554
of 2,126 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOEY INVESTMENTS, INC holds $4,107,250 across 15 Drug Manufacturers - General names. JNJ ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,928 | $1,784,527 | |
| 2 | ABBV |
AbbVie Inc.
|
4,275 | $1,075,761 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
2,250 | $571,432 | |
| 4 | GSK |
GSK plc
|
4,897 | $256,700 | |
| 5 | LLY |
ELI LILLY & Co
|
187 | $224,293 | |
| 6 | PFE |
Pfizer Inc
|
5,827 | $140,314 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 | |
| 8 | AZN |
Astrazeneca PLC
|
77 | $14,600 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $571,432 | 2,250 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $606,944 | 2,483 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $524,204 | 2,533 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $469,668 | 2,533 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $341,090 | 2,233 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $455,396 | 2,746 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $348,968 | 2,413 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $329,467 | 2,033 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $297,143 | 2,033 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,663,128 | 16,835 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,330,098 | 21,246 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,643,771 | 23,395 | Shares | Sole | 2024-04-22 | |
| 2023-06-30 | $4,095,130 | 24,741 | Shares | Sole | 2024-04-22 | |
| 2023-03-31 | $5,538,305 | 35,731 | Shares | Sole | 2024-04-22 | |
| 2022-12-31 | $6,376,535 | 36,097 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,051,597 | 43,166 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,970,021 | 44,899 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,152,757 | 46,001 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $8,088,189 | 47,280 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,450,964 | 46,136 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,081,650 | 49,057 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $7,434,043 | 45,233 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $7,064,001 | 44,885 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $5,995,695 | 40,272 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $4,014,705 | 28,548 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $2,085,098 | 15,901 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||